Fingerprint
Dive into the research topics of 'A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically